A close look at the top cancer therapeutics drugs in development from the most well-funded private companies.
The search for potential cancer cures continues with many private companies working across every phase on the clinical trial process.
Using the CB Insights platform, we analyzed the top 18 most well-funded private cancer therapeutics companies that have raised funding since 2015 and where they’re developing their R&D pipelines along with the types of cancer they’re targeting.
We define the cancer drug startup space to include pharmaceutical and biotech companies in the drug discovery and/or development phase with a stated focus on cancer therapeutics. We exclude areas such as medical devices & diagnostics (e.g. instrumentation, delivery systems), genetic testing platforms, and digital health.
matrix: MOST WELL-FUNDED cancer therapeutics companies
The top 18 most well-funded private cancer therapeutics companies below are categorized based on the primary type of cancer therapy they’re developing, the specific cancers they’re targeting, along with the clinical trial stage of their primary product(s) and total disclosed funding. Each company’s leading cancer product(s) were determined by the information presented on their respective websites or on ClinicalTrials.Gov.
Clinical trial stages are categorized as pre-clinical, phase 1, phase 2, or phase 3+.